Identifiering av biomarkörer för utveckling av kronisk lungfibros i Covid-19 patienter

Pulmonary fibrosis is a severe and life shortening chronic condition. Although most people experience mild symptoms of COVID-19, some patients develop serious and life-threatening conditions with severe lung damage. In order to influence the outcome of the disease, the project aims to establish methods to identify risk groups at an early stage.